Explore more publications!
Middle East Tech Today
Submit Press Release

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 8, 2025

Korean Biometric Firm ETUNNEL Unlocks Future of Hyper-Personalized Living
October 8, 2025

Korean Biometric Firm ETUNNEL Unlocks Future of Hyper-Personalized Living

Indeterminate EIN Presswire
PROVEN strengthens portfolio by consolidating subsidiaries under 'PROVEN Solution'
October 8, 2025

PROVEN strengthens portfolio by consolidating subsidiaries under 'PROVEN Solution'

Indeterminate EIN Presswire
AmiViz Partners with Corgea to Strengthen Code Security Across the Middle East
October 8, 2025

AmiViz Partners with Corgea to Strengthen Code Security Across the Middle East

Indeterminate EIN Presswire
Longevity Expert Establishes a New Benchmark in Consciousness Detection - New Future for Brain-Computer Interfaces?
October 8, 2025

Longevity Expert Establishes a New Benchmark in Consciousness Detection - New Future for Brain-Computer Interfaces?

Indeterminate EIN Presswire
Blockchain Life 2025 in Dubai – The Legendary Akon will Perform an Exclusive Set at the Official Afterparty
October 8, 2025

Blockchain Life 2025 in Dubai – The Legendary Akon will Perform an Exclusive Set at the Official Afterparty

Indeterminate EIN Presswire
Growing at 18.3% CAGR | Cloud Retail Market Reach USD 216.2 Billion by 2032 Globally
October 8, 2025

Growing at 18.3% CAGR | Cloud Retail Market Reach USD 216.2 Billion by 2032 Globally

Indeterminate EIN Presswire
TierOne to Showcase NaaS CX, Smart NOC, and NaaS NOC Solutions at GITEX 2025
October 8, 2025

TierOne to Showcase NaaS CX, Smart NOC, and NaaS NOC Solutions at GITEX 2025

Indeterminate EIN Presswire
IPQS Launches Enterprise Fintech Solutions & Partnerships
October 8, 2025

IPQS Launches Enterprise Fintech Solutions & Partnerships

Indeterminate EIN Presswire
Game On with the Gaming Giants: Global Games Show 2025 Unveils Exclusive Speaker Lineup
October 8, 2025

Game On with the Gaming Giants: Global Games Show 2025 Unveils Exclusive Speaker Lineup

Indeterminate EIN Presswire
Digital Zone Explores New Partnerships at HITEX 2025
October 8, 2025

Digital Zone Explores New Partnerships at HITEX 2025

Indeterminate EIN Presswire
Google’s 'AI Home' Moment Proves the Future We’ve Been Building All Along
October 8, 2025

Google’s 'AI Home' Moment Proves the Future We’ve Been Building All Along

Indeterminate EIN Presswire
Globaliser Announces Hermes Cache Pro: Multi-Location In-Memory Cache Globally for WordPress & WooCommerce
October 8, 2025

Globaliser Announces Hermes Cache Pro: Multi-Location In-Memory Cache Globally for WordPress & WooCommerce

Indeterminate EIN Presswire
Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer
October 8, 2025

Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer

Indeterminate GlobeNewswire
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
October 8, 2025

Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo

Indeterminate GlobeNewswire
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
October 8, 2025

Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…

Indeterminate GlobeNewswire
Nilo Therapeutics מושקה עם מימון סדרה A של 101 מיליון דולר לקידום סוג חדש של תרופות המכוונות למעגלים עצביים במחלות חיסוניות וממנה את קים סת' למנכ"ל
October 8, 2025

Nilo Therapeutics מושקה עם מימון סדרה A של 101 מיליון דולר לקידום סוג חדש של תרופות המכוונות למעגלים עצביים במחלות חיסוניות וממנה את קים סת' למנכ"ל

Indeterminate GlobeNewswire
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
October 8, 2025

ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…

Indeterminate GlobeNewswire
Nilo Therapeutics diluncurkan dengan pendanaan Seri A senilai 101 juta dolar AS untuk mengembangkan kelas baru obat-obatan yang menargetkan sirkuit saraf pada penyakit imun, serta menunjuk Kim Seth sebagai Direktur Utama
October 8, 2025

Nilo Therapeutics diluncurkan dengan pendanaan Seri A senilai 101 juta dolar AS untuk mengembangkan kelas baru obat-obatan yang menargetkan sirkuit saraf pada penyakit imun, serta menunjuk Kim Seth sebagai Direktur Utama

Indeterminate GlobeNewswire
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif
October 8, 2025

Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

Indeterminate GlobeNewswire
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
October 8, 2025

Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions